Moreno-Fernandez J., Chico A., Martínez-Brocca M.A., Beato-Víbora P.I., Vidal M., Piedra M., Quirós C., Muñoz-Rodríguez J.R.. Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes Mellitus Patients: Results from the Spanish National Registry. Diabetes Technology & Therapeutics. 2022; 24(12)DOI:10.1089/dia.2022.0207. PMID:35947087. IF:5.400(Q1/3D).

Casas J.A.V., Sambo M., López C.L., Durán-Poveda M., García J.R.-V., Santos R.J., Llanos M., Navarro-González E., Aller J., Pubul V., Guadalix S., Crespo G., González C., Zafón C., Navarro M., Santamaría-Sandi J., Segura Á., Gajate P., Gómez-Balaguer M., Valdivia J., Puig-Domingo M., Galofré J.C., Castelo B., Villanueva M.J., Argüelles I., Orcajo-Rincón L.. Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study. European Thyroid Journal. 2022; 11(5)DOI:10.1530/ETJ-21-0111. PMID:35900793. IF:4.700(Q2/3D).

Pérez Pérez A., Ortega Martínez de Victoria E., Arrieta Blanco F., Caixàs Pedragós A., Santos Mazo E., Fernández-Catalina P., Martínez-Hervas S., López-Medina J.A., Suárez-Gutiérrez L., Urgeles Planelles J.R., Gatell Menchén S., Tinahones Madueño F.. First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: a retrospective observational study (RETOSS-ENDO). Endocrinologia Diabetes y Nutricion. 2022; 69(7)DOI:10.1016/j.endinu.2021.07.009. PMID:35995680. IF:1.900(Q4/9D).

Tomic D., Morton J.I., Chen L., Salim A., Gregg E.W., Pavkov M.E., Arffman M., Balicer R., Baviera M., Boersma-van Dam E., Brinks R., Carstensen B., Chan J.C.N., Cheng Y.J., Fosse-Edorh S., Fuentes S., Gardiner H., Gulseth H.L., Gurevicius R., Ha K.H., Hoyer A., Jermendy G., Kautzky-Willer A., Keskimäki I., Kim D.J., Kiss Z., Klimek P., Leventer-Roberts M., Lin C.-Y., Lopez-Doriga Ruiz P., Luk A.O.Y., Ma S., Mata-Cases M., Mauricio D., McGurnaghan S., Imamura T., Paul S.K., Peeters A., Pildava S., Porath A., Robitaille C., Roncaglioni M.C., Sugiyama T., Wang K.-L., Wild S.H., Yekutiel N., Shaw J.E., Magliano D.J.. Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study. Lancet Diabetes & Endocrinology. 2022; 10(11)DOI:10.1016/S2213-8587(22)00252-2. PMID:36183736. IF:44.500(Q1/1D).

Puig-Jové, C, Viñals, C, Conget, I, Quirós, C, Vinagre, I, Berrocal, B, Blanco-Carrasco, AJ, Granados, M, Mesa, A, Serés-Noriega, T, Giménez, M, Perea, V, Amor, AJ. Association between the GMI/HbA1c ratio and preclinical carotid atherosclerosis in type 1 diabetes: impact of the fast-glycator phenotype across age groups. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02637-4. PMID:39953520. IF:10.600(Q1/1D).

Gourdy, P, Bonadonna, RC, Mauricio, D, Müller-Wieland, D, Mauquoi, C, Vera, C, Bonnemaire, M, Freemantle, N. Effectiveness and safety of insulin glargine 300 U/mL in insulin-naïve individuals according to diabetes duration: Results from the REALI European pooled data analysis. DIABETES OBESITY & METABOLISM. 2025; 27(1)DOI:10.1111/dom.16008. PMID:39420531. IF:5.700(Q1/2D).

Fernandez-Camins, B, Vlacho, B, Canudas, A, Ortega, M, Granado-Casas, M, Perera-LLuna, A, Boluda-Sanson, A, El-Khattabi-Ofkir, Y, Franch-Nadal, J, Mauricio, D. Characterisation of type 2 diabetes subgroups at diagnosis: the COPERNICAN prospective observational cohort study protocol. BMJ Open. 2024; 14(12)DOI:10.1136/bmjopen-2023-083825. PMID:39675821. IF:2.300(Q2/3D).

Beato-Víbora, PI, Chico, A, Moreno-Fernandez, J, Bellido-Castañeda, V, Nattero-Chávez, L, Picón-César, MJ, Martínez-Brocca, MA, Giménez-Alvarez, M, Aguilera-Hurtado, E, Climent-Biescas, E, Azriel-Mir, S, Rebollo-Román, A, Yoldi-Vergara, C, Pazos-Couselo, M, Alonso-Carril, N, Quirós, C. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting (vol 47, pg 216, 2024). DIABETES CARE. 2024; 47(12)DOI:10.2337/dc24-er12a. PMID:39265091. IF:16.600(Q1/1D).

Antentas, M, Rojo-López, MI, Vendrell, P, Granado-Casas, M, Genua, I, Fernandez-Camins, B, Rossell, J, Niño-Narvión, J, Moreira, E, Castelblanco, E, Ortega, E, Vlacho, B, Alonso, N, Mauricio, D, Julve, J. Impact of Dietary Niacin on Metabolic Dysfunction-Associated Steatotic Liver Disease in Mediterranean Subjects: A Population-Based Study. Nutrients. 2024; 16(23)DOI:10.3390/nu16234178. PMID:39683571. IF:5.000(Q1/2D).

Hernández-Teixidó, C, de la Puente, JB, Jiménez, SM, Fernández-Camins, B, Mauricio, D, Aroca, PR, Vlacho, B, Franch-Nadal, J. Incidence of Diabetic Retinopathy in Individuals with Type 2 Diabetes: A Study Using Real-World Data. Journal of Clinical Medicine. 2024; 13(23)DOI:10.3390/jcm13237083. PMID:39685542. IF:2.900(Q1/2D).

Magliano, DJ, Chen, L, Morton, J, Salim, A, Carstensen, B, Gregg, EW, Pavkov, ME, Arffman, M, Colhoun, HM, Ha, KH, Imamura, T, Jermendy, G, Kim, DJ, Kiss, Z, Mauricio, D, Mcgurnaghan, SJ, Nishioka, Y, Wild, SH, Winell, K, Shaw, JE. Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortium. Lancet Diabetes & Endocrinology. 2024; 12(12)DOI:10.1016/S2213-8587(24)00243-2. PMID:39541997. IF:41.800(Q1/1D).

Rojo-López, MI, Bermúdez-López, M, Castro, E, Farràs, C, Torres, G, Pamplona, R, Lecube, A, Valdivieso, JM, Fernández, E, Julve, J, Castelblanco, E, Alonso, N, Antentas, M, Barranco-Altirriba, M, Perera-Lluna, A, Franch-Nadal, J, Granado-Casas, M, Mauricio, D. Mediterranean Diet Is a Predictor of Progression of Subclinical Atherosclerosis in a Mediterranean Population: The ILERVAS Prospective Cohort Study. Nutrients. 2024; 16(21)DOI:10.3390/nu16213607. PMID:39519440. IF:5.000(Q1/2D).

Cheng, AYY, Mauricio, D, Ritzel, R, Al-Sofiani, ME, Bailey, T, Mabunay, MA, Bonnemaire, M, Melas-Melt, L, Mimouni, S, Davies, M. A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy. DIABETES RESEARCH AND CLINICAL PRACTICE. 2024; 217DOI:10.1016/j.diabres.2024.111871. PMID:39343145. IF:7.400(Q1/1D).

Facundo, AN, Magalhaes, M, Nascimento, GC, Azulay, RS, Santos, RM, Freitas, LA, Nascimento, AGPAC, Rodrigues, VP, Santos, WC, Beckman, AMGS, Abreu, JMF, Silva, RP, Carneiro, EL, Neto, CPO, da Costa, RMG, Corcoy, R, Mato, E, Faria, MS. The expression of VDACs and Bcl2 family genes in pituitary adenomas: clinical correlations and postsurgical outcomes. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1481050. PMID:39449743. IF:4.600(Q1/3D).

Genua, I, Sardà, H, Pérez, A. Cardiometabolic effects of weight loss. Atencion Primaria. 2024; 56(10)DOI:10.1016/j.aprim.2024.102953. PMID:38705132. IF:1.600(Q2/4D).

Pérez, A. GLP-1 receptor agonists in clinical practice. MEDICINA CLINICA. 2024; 163(5)DOI:10.1016/j.medcli.2024.02.018. PMID:38688736. IF:2.100(Q2/3D).

Somolinos-Simón, FJ, García-Sáez, G, Tapia-Galisteo, J, Corcoy, R, Hernando, ME. Cluster analysis of adult individuals with type 1 diabetes: Treatment pathways and complications over a five-year follow-up period. DIABETES RESEARCH AND CLINICAL PRACTICE. 2024; 215DOI:10.1016/j.diabres.2024.111803. PMID:39089589. IF:7.400(Q1/1D).

Cheng, A, Mauricio, D, Ritzel, R, Al-Sofiani, ME, Bailey, T, Mabunay, M, Bonnemaire, M, Lydie, MM, Mimouni, S, Davies, M. Efficacy and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).

Claramunt, FC, Lazaro, D, Salter, J, Paldánius, P, Mauricio, D. Non-invasive near-infrared system for screening for diabetes: first results from the ANODE03 clinical investigation. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).

Torre, ELM, Alarcón, PP, Rodríguez, MM, Serrallonga, NB, Palomar, JR, Iglesias, DM, Hoyas, CN, Servat, OS, Kyriakos, G, Bellas, LC, Pla, RC, Ramonde, TM, López, ML, Madorell, BS, Borrás, JG. Open-label, descriptive, sequential study in type 1 diabetes patients to evaluate the Mylife™-Dose app with ISCI and compare it to a hybrid continuous insulin infusion system (CamAPS): Dose Human Loop study. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).

Rosales, A, Gil, P, Julian, T, Teis, A, Pedraz, B, Sanchez, J, Julve, J, Mauricio, D, Perez, A, Alonso, N. Myocardial steatosis and improvement of cardiac function after glycaemic optimisation treatment in newly diagnosed type 2 diabetes subjects. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).

Vlacho, B, Iniesta, AM, Gratacòs, M, Mata-Cases, M, Rubinat, E, Berenguera, A, Cos, FX, Franch-Nadal, J, Mauricio, D. Effectiveness of a multicomponent healthcare intervention on blood pressure and lipids among subjects with poorly controlled type 2 diabetes: Findings from the INTEGRA study. Primary Care Diabetes. 2024; 18(4)DOI:10.1016/j.pcd.2024.05.001. PMID:38782704. IF:2.300(Q2/5D).

Giné, LC, Caro-Pérez, P, Villanueva-Carmona, T, Rodríguez-Peña, MM, Núñez-Roa, C, Granado-Casas, M, Santos, D, Mauricio, D, Rotllan, N, Escola-Gil, JC, Vendrell, J, Fernández-Veledo, S. DECIPHERING THE EXTRACELLULAR EFFECTS OF SUCCINATE IN ATHEROSCLEROTIC DISEASE PROGRESSION: A TRANSLATIONAL APPROACH. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).

Orna, JAG, Martínez, ABM, Padial, LR, Sánchez, MA, Barrios, V, García, JM, Perez, AP. Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial. Endocrinologia Diabetes y Nutricion. 2024; 71(7)DOI:10.1016/j.endien.2024.07.001. PMID:39095283. IF:1.800(Q3/8D).

Manzanares, RG, Gamez, MA, Garcia, JM, Orna, JAG, Perez, AP, Barrios, V, Padial, LR, Sanchez, MMPA. Prevalence and incidence of heart failure in patients with type 2 diabetes mellitus. Results of the prospective DIABET-IC study. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).

Ramos-Molina, B, Rossell, J, de Oca, APM, Pardina, E, Genua, I, Rojo-Lopez, MI, Julian, MT, Alonso, N, Julve, J, Mauricio, D. Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1400961. PMID:38962680. IF:4.600(Q1/3D).

Vlacho, B, Bundó, M, Llussà, J, Real, J, Mata-Cases, M, Cos, X, Tundidor, D, Zaccardi, F, Khunti, K, Jude, EB, Franch-Nadal, J, Mauricio, D. Diabetic foot disease carries an intrinsic high risk of mortality and other severe outcomes in type 2 diabetes: a propensity score-matched retrospective population-based study. Cardiovascular Diabetology. 2024; 23(1)DOI:10.1186/s12933-024-02303-1. PMID:38898525. IF:10.600(Q1/1D).

Masson, W, Barbagelata, L, Godinez-Leiva, E, Genua, I, Nogueira, JP. Association between hepatic steatosis and lipoprotein(a) levels in non-alcoholic patients: A systematic review. Indian Journal Of Gastroenterology. 2024; 43(3)DOI:10.1007/s12664-023-01457-2. PMID:38036914. IF:(Q/D).

Rojo-López, MI, Barranco-Altirriba, M, Rossell, J, Antentas, M, Castelblanco, E, Yanes, O, Weber, RJM, Lloyd, GR, Winder, C, Dunn, WB, Julve, J, Granado-Casas, M, Mauricio, D. The Lipidomic Profile Is Associated with the Dietary Pattern in Subjects with and without Diabetes Mellitus from a Mediterranean Area. Nutrients. 2024; 16(12)DOI:10.3390/nu16121805. PMID:38931159. IF:5.000(Q1/2D).

Espinosa, EVP, Matute, EM, Guzman, DMS, Khasawneh, FT. The Polypill: A New Alternative in the Prevention and Treatment of Cardiovascular Disease. Journal of Clinical Medicine. 2024; 13(11)DOI:10.3390/jcm13113179. PMID:38892892. IF:2.900(Q1/2D).

Peraile, MA, Rojo-López, MI, Vlacho, B, Rossell, J, Vendrell, P, Genua, I, Fernández-Camins, B, Granado-Casas, M, Mauricio, D, Julve, J. Sex-specific disparities in dietary patterns and their association with metabolic-associated fatty liver disease. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).

Quirós, C, Arranz, MTH, Amigó, J, Wägner, AM, Beato-Vibora, PI, Azriel-Mira, S, Climent, E, Soldevila, B, Barquiel, B, Colomo, N, Durán-Martínez, M, Corcoy, R, Codina, M, Díaz-Soto, G, Pardo, RM, Martínez-Brocca, MA, Roman, AR, López-Gallardo, G, Cuesta, M, Fernández, JG, Goya, M, Guedes, BV, Mathison, LCM, Perea, V. Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes. Diabetes Technology & Therapeutics. 2024; DOI:10.1089/dia.2023.0594. PMID:38417014. IF:6.300(Q1/2D).

Jiménez, A, Vlacho, B, Mata-Cases, M, Real, J, Mauricio, D, Franch-Nadal, J, Ortega, E. Sex and age significantly modulate cardiovascular disease presentation in type 2 diabetes: a large population-based cohort study. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1344007. PMID:38828412. IF:4.600(Q1/3D).

Genua, I, Ramos, A, Caimari, F, Balagué, C, Sánchez-Quesada, JL, Pérez, A, Miñambres, I. Effects of Bariatric Surgery on HDL Cholesterol (vol 30, pg 1793, 2020). OBESITY SURGERY. 2024; 34(6)DOI:10.1007/s11695-024-07263-9. PMID:38710974. IF:3.100(Q1/2D).

Gomez-Peralta, F, Ballesteros, AC, Martínez, AM, Corral, BP, Donlo, IC, Melo, PF, Arnáez, FZ, Rodríguez, MM. Insulin glargine 300 U/ml versus insulin degludec 100 U/ml improves nocturnal glycaemic control and variability in type 1 diabetes under routine clinical practice: A glucodensities-based post hoc analysis of the OneCare study. DIABETES OBESITY & METABOLISM. 2024; 26(5)DOI:10.1111/dom.15496. PMID:38379106. IF:5.700(Q1/2D).

Beato-Vibora, PI, Chico, A, Moreno-Fernandez, J, Bellido-Castañeda, V, Nattero-Chávez, L, Picón-César, MJ, Martínez-Brocca, MA, Gimenez-Alvarez, M, Aguilera-Hurtado, E, Climent-Biescas, E, Azriel-Mira, S, Rebollo-Román, A, Yoldi-Vergara, C, Pazos-Couselo, M, Alonso-Carril, N, Quirós, C. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting Response. DIABETES CARE. 2024; 47(5)DOI:10.2337/dci24-0017. PMID:38640410. IF:16.600(Q1/1D).

Guardiola, M, Rehues, P, Amigó, N, Arrieta, F, Botana, M, Gimeno-Orna, JA, Girona, J, Martínez-Montoro, JI, Ortega, E, Pérez-Pérez, A, Sánchez-Margalet, V, Pedro-Botet, J, Ribalta, J. Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54(8)DOI:10.1111/eci.14214. PMID:38613414. IF:3.600(Q1/2D).

Oram, RA, Grif, KJ, Tobias, DK, Merino, J, Ahmad, A, Aiken, C, Benham, JL, Bodhini, D, Clark, AL, Colclough, K, Corcoy, R, Cromer, SJ, Duan, D, Felton, JL, Francis, EC, Gillard, P, Gingras, V, Gaillard, R, Haider, E, Hughes, A, Ikle, JM, Jacobsen, LM, Kahkoska, AR, Kettunen, JLT, Kreienkamp, RJ, Lim, LL, Männistö, JME, Massey, R, Mclennan, NM, Miller, RG, Morieri, ML, Most, J, Naylor, RN, Ozkan, B, Patel, KA, Pilla, SJ, Prystupa, K, Raghavan, S, Rooney, MR, Schön, M, Semnani-Azad, Z, Sevilla-Gonzalez, M, Svalastoga, P, Takele, WW, Tam, CHT, Thuesen, ACB, Tosur, M, Wallace, AS, Wang, CC, Wong, JJ, Yamamoto, JM, Young, K, Amouyal, C, Andersen, MK, Bonham, MP, Chen, ML, Cheng, FF, Chikowore, T, Chivers, SC, Clemmensen, C, Dabelea, D, Dawed, AY, Deutsch, AJ, Dickens, LT, DiMeglio, LA, Dudenhöffer-Pfeifer, M, Evans-Molina, C, Fernández-Balsells, MM, Fitipaldi, H, Fitzpatrick, SL, Gitelman, SE, Goodarzi, MO, Grieger, JA, Guasch-Ferré, M, Habibi, N, Hansen, T, Huang, CG, Harris-Kawano, A, Ismail, HM, Hoag, B, Johnson, RK, Jones, AG, Koivula, RW, Leong, A, Leung, GKW, Libman, IM, Liu, K, Long, SA, Lowe, WL, Morton, RW, Motala, AA, Onengut-Gumuscu, S, Pankow, JS, Pathirana, M, Pazmino, S, Perez, D, Petrie, JR, Powe, CE, Quinteros, A, Jain, R, Ray, D, Ried-Larsen, M, Saeed, Z, Santhakumar, V, Kanbour, S, Sarkar, S, Monaco, GSF, Scholtens, DM, Selvin, E, Sheu, WHH, Speake, C, Stanislawski, MA, Steenackers, N, Steck, AK, Stefan, N, Stoy, J, Taylor, R, Tye, SC, Ukke, GG, Urazbayeva, M, Van der Schueren, B, Vatier, C, Wentworth, JM, Hannah, W, White, SL, Yu, GC, Zhang, YC, Zhou, SJ, Beltrand, J, Polak, M, Aukrust, I, de Franco, E, Flanagan, SE, Maloney, KA, McGovern, A, Molnes, J, Nakabuye, M, Njolstad, PR, Pomares-Millan, H, Provenzano, M, Saint-Martin, C, Zhang, CL, Zhu, YY, Auh, S, de Souza, R, Fawcett, AJ, Gruber, C, Mekonnen, EG, Mixter, E, Sherifali, D, Eckel, RH, Nolan, JJ, Philipson, LH, Brown, RJ, Billings, LK, Boyle, K, Costacou, T, Dennis, JM, Florez, JC, Gloyn, AL, Gomez, MF, Gottlieb, PA, Greeley, SAW, Griffin, K, Hattersley, AT, Hirsch, IB, Hivert, MF, Hood, KK, Josefson, JL, Kwak, SH, Laffel, LM, Lim, SS, Loos, RJF, Ma, RCW, Mathieu, C, Mathioudakis, N, Meigs, JB, Misra, S, Mohan, V, Murphy, R, Oram, R, Owen, KR, Ozanne, SE, Pearson, ER, Perng, W, Pollin, TI, Pop-Busui, R, Pratley, RE, Redman, LM, Redondo, MJ, Reynolds, RM, Semple, RK, Sherr, JL, Sims, EK, Sweeting, A, Tuomi, T, Udler, MS, Vesco, KK, Vilsboll, T, Wagner, R, Rich, SS, Franks, PW. Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review. Communications Medicine. 2024; 4(1)DOI:10.1038/s43856-024-00478-y. PMID:38582818. IF:(Q/D).

Gómez-Peralta, F, Menéndez, E, Conde, S, Abellán-Galiana, P, Brito, M, Beléndez, M, Pérez, A. Metabolic and Clinical Outcomes in Type 1 Diabetes in the COVID-19 Pre- and Post-Vaccination Periods in Spain: The COVID-SED1 Study. Journal of Clinical Medicine. 2024; 13(7)DOI:10.3390/jcm13071922. PMID:38610687. IF:2.900(Q1/2D).

Salina-Roca, B, Sánchez, E, Bermúdez-López, M, Valdivielso, JM, Farràs-Sallés, C, Pamplona, R, Torres, G, Mauricio, D, Castro, E, Fernández, E, Hernández, M, Rius, F, Lecube, A. Association between adherence to the mediterranean diet, physical activity, and sleep apnea-hypopnea syndrome (SAHS) in a middle-aged population with cardiovascular risk: Insights from the ILERVAS cohort. SLEEP MEDICINE. 2024; 116DOI:10.1016/j.sleep.2024.02.032. PMID:38408422. IF:3.400(Q2/3D).

Mauricio, D, Escalada, J, Pérez, A, Romero-Gómez, M, Cusi, K, Younoussi, ZM, Lazarus, JV. Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists. Endocrinologia Diabetes y Nutricion. 2024; 71(4)DOI:10.1016/j.endien.2024.01.007. PMID:38735676. IF:1.800(Q3/8D).

Barranco-Altirriba, M, Alonso, N, Weber, RJM, Lloyd, GR, Hernandez, M, Yanes, O, Capellades, J, Jankevics, A, Winder, C, Falguera, M, Franch-Nadal, J, Dunn, WB, Perera-Lluna, A, Castelblanco, E, Mauricio, D. Lipidome characterisation and sex-specific differences in type 1 and type 2 diabetes mellitus. Cardiovascular Diabetology. 2024; 23(1)DOI:10.1186/s12933-024-02202-5. PMID:38553758. IF:10.600(Q1/1D).

Folle, AM, Magallanes, SL, Fló, M, Alvez-Rosado, R, Carrión, F, Vallejo, C, Watson, D, Julve, J, González-Sapienza, G, Pristch, O, González-Techera, A, Ferreira, AM. Modulatory actions of Echinococcus granulosus antigen B on macrophage inflammatory activation. Frontiers in Cellular and Infection Microbiology. 2024; 14DOI:10.3389/fcimb.2024.1362765. PMID:38562963. IF:4.800(Q1/2D).

Monroy, G, Fernández, C, Altimira, L, Barba, U, Corcoy, R. Postpartum oral glucose tolerance test in women with prior gestational diabetes. Does breastfeeding affect the results? Analysis of hormonal profiles. DIABETIC MEDICINE. 2024; 41(6)DOI:10.1111/dme.15315. PMID:38451734. IF:3.400(Q2/4D).

Xie X., Liu J., García-Patterson A., Chico A., Mateu-Salat M., Amigó J., Adelantado J.M., Corcoy R.. Gestational weight gain in women with type 1 and type 2 diabetes mellitus is related to both general and diabetes-related clinical characteristics. Hormones-International Journal of Endocrinology and Metabolism. 2024; 23(1)DOI:10.1007/s42000-023-00497-9. PMID:37845472. IF:2.500(Q3/7D).

Vlacho, B, Fernandez-Camins, B, Canudas-Ventura, A, Rodríguez, A, Mollo, A, Claramunt, FXC, Antentas, M, Mauricio, D, Franch-Nadal, J. Performance of Primary Care Physicians in the Management of Glycemia, Lipids, and Blood Pressure among People with Type 2 Diabetes: A Cross-Sectional Study. Journal of Clinical Medicine. 2024; 13(6)DOI:10.3390/jcm13061544. PMID:38541770. IF:2.900(Q1/2D).

Ramírez-Morros, A, Franch-Nadal, J, Real, J, Miró-Catalina, Q, Bundó, M, Vlacho, B, Mauricio, D. Clinical characteristics and degree of cardiovascular risk factor control in patients with newly-diagnosed type 2 diabetes in Catalonia. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1339879. PMID:38390201. IF:4.600(Q1/3D).

Ma, CX, Ma, XN, Liu, JJ, Guan, CH, Li, YD, Zhao, N, Mauricio, D, Fu, SB. The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2024; 581DOI:10.1016/j.mce.2023.112113. PMID:37989409. IF:3.600(Q2/4D).

Beato-Víbora, PI, Chico, A, Moreno-Fernandez, J, Bellido-Castañeda, V, Nattero-Chávez, L, Picón-César, MJ, Martínez-Brocca, MA, Giménez-Alvarez, M, Aguilera-Hurtado, E, Climent-Biescas, E, Azriel-Mir, S, Rebollo-Román, A, Yoldi-Vergara, C, Pazos-Couselo, M, Alonso-Carril, N, Quirós, C. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. DIABETES CARE. 2024; 47(2)DOI:10.2337/dc23-1355. PMID:37948469. IF:16.600(Q1/1D).

Sloan, L, Cheng, AYY, Escalada, J, Haluzík, M, Mauricio, D. The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review. DIABETES OBESITY & METABOLISM. 2024; 26(4)DOI:10.1111/dom.15425. PMID:38225217. IF:5.700(Q1/2D).

Rotllan N, Julve J, Escolà-Gil JC. Type 2 Diabetes and HDL dysfunction: a key contributor to Glycemic Control.. CURRENT MEDICINAL CHEMISTRY. 2024; 31(3)DOI:10.2174/0929867330666230201124125. PMID:36722477. IF:3.500(Q2/4D).

Chico A., Moreno-Fernández J., Fernández-García D., Solá E.. The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization. Diabetes Therapy. 2024; 15(1)DOI:10.1007/s13300-023-01486-2. PMID:37857988. IF:2.600(Q3/6D).

Rodríguez-Agudo, R, González-Recio, I, Serrano-Maciá, M, Bravo, M, Petrov, P, Blaya, D, Herranz, JM, Mercado-Gómez, M, Rejano-Gordillo, CM, Lachiondo-Ortega, S, Gil-Pitarch, C, Azkargorta, M, Van Liempd, SM, Martinez-Cruz, LA, Simao, AL, Elortza, F, Martín, C, Nevzorova, YA, Cubero, FJ, Delgado, TC, Argemi, J, Bataller, R, Schoonjans, K, Banales, JM, Castro, RE, Sancho-Bru, P, Avila, MA, Julve, J, Jover, R, Mabe, J, Simon, J, Goikoetxea-Usandizaga, N, Martínez-Chantar, ML. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1. Jhep Reports. 2024; 6(1)DOI:10.1016/j.jhepr.2023.100918. PMID:38192540. IF:7.500(Q1/2D).

Soldevila B., Alarcón L., Vlacho B., Real J., Hernández M., Cos X., Franch-Nadal J., Mauricio D.. Trends in the prevalence of gestational diabetes in Catalonia from 2010 to 2019. Primary Care Diabetes. 2024; 18(2)DOI:10.1016/j.pcd.2023.12.007. PMID:38228411. IF:2.300(Q2/5D).

Gómez-Peralta, F, Valledor, X, López-Picado, A, Abreu, C, Fernández-Rubio, E, Cotovad, L, Pujante, P, García-Fernández, E, Azriel, S, Corcoy, R, Pérez-González, J, Ruiz-Valdepeñas, L. Ultrarapid Insulin Use Can Reduce Postprandial Hyperglycemia and Late Hypoglycemia, Even in Delayed Insulin Injections: A Connected Insulin Cap-Based Real-World Study. Diabetes Technology & Therapeutics. 2024; 26(1)DOI:10.1089/dia.2023.0321. PMID:37902762. IF:6.300(Q1/2D).

Ramírez-Morros, A, Berenguera, A, Millaruelo, L, Buil-Cosiales, P, Garcia, CG, Cos, X, Lachica, LA, Artola, S, Millaruelo, JM, Mauricio, D, Franch-Nadal, J. Impact of Gender on Patient Experiences of Self-Management in Type 2 Diabetes: A Qualitative Study. Patient Preference and Adherence. 2024; 18DOI:10.2147/PPA.S466931. PMID:39290823. IF:2.000(Q2/4D).

Durán-Martínez, M, Azriel, S, Doulatram-Gamgaram, VK, Moreno-Pérez, O, Pines-Corrales, PJ, Tejera-Pérez, C, Merino-Torres, JF, Brito-Sanfiel, M, Chico, A, Marco, A, García-Fernández, E, Martínez-Montoro, JI. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study. DIABETES & METABOLISM. 2024; 50(1)DOI:10.1016/j.diabet.2023.101501. PMID:38061425. IF:4.700(Q1/3D).

Escalada J., Pérez A., Rica I.. Is the Spanish type 1 diabetes mellitus registry really necessary?. Endocrinologia Diabetes y Nutricion. 2023; 70(10)DOI:10.1016/j.endinu.2023.05.002. PMID:38000969. IF:1.800(Q3/8D).

López-Yerena, A, Padro, T, Villaplana, VD, Muñoz-García, N, Pérez, A, Vilahur, G, Badimon, L. Vascular and Platelet Effects of Tomato Soffritto Intake in Overweight and Obese Subjects. Nutrients. 2023; 15(24)DOI:10.3390/nu15245084. PMID:38140343. IF:4.800(Q1/2D).

Roth, L, Dogan, S, Tuna, BG, Aranyi, T, Benitez, S, Borrell-Pages, M, Bozaykut, P, De Meyer, GRY, Duca, L, Durmus, N, Fonseca, D, Fraenkel, E, Gillery, P, Giudici, A, Jaisson, S, Johansson, M, Julve, J, Lucas-Herald, AK, Martinet, W, Maurice, P, McDonnell, BJ, Ozbek, EN, Pucci, G, Pugh, CJA, Rochfort, KD, Roks, AJM, Rotllan, N, Shadiow, J, Sohrabi, Y, Spronck, B, Szeri, F, Terentes-Printzios, D, Aydin, ET, Tura-Ceide, O, Ucar, E, Yetik-Anacak, G. Pharmacological modulation of vascular ageing: A review from VascAgeNet. AGEING RESEARCH REVIEWS. 2023; 92DOI:10.1016/j.arr.2023.102122. PMID:37956927. IF:12.500(Q1/1D).